We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arrowhead Research Corporation Acquires Alvos Therapeutics

News   Apr 12, 2012

 
Arrowhead Research Corporation Acquires Alvos Therapeutics
 
 
 

RELATED ARTICLES

Prescription Omega-3 Fatty Acid Meds Lower High Triglycerides by 20–30%

News

Prescription omega-3 fatty acid medication reduces triglyceride levels by 20-30% among the majority of people who require treatment for high triglyceride levels, according to a science advisory from the American Heart Association.

READ MORE

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

Grant Fuels Drug Discovery Efforts for ALS

News

Scientists have received a $3.1 million grant to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE